Skip to main content

MoneyWorks4Me

Cohance Lifesciences informs about disclosure

19 Jun 2026 Evaluate

Cohance Lifesciences has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore).

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..